• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
Classification Nameprosthesis, intervertebral disc
Generic Nameprosthesis, intervertebral disc
Medtronic Sofamor Danek USA, Inc.
1800 pyramid place
memphis, TN 38132
PMA NumberP060023
Date Received06/29/2006
Decision Date05/12/2009
Product Code
MJO[ Registered Establishments with MJO ]
Docket Number 09M-0243
Notice Date 05/27/2009
Advisory Committee Orthopedic
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the bryan cervical disc. The device is indicated in skeletally mature patients for reconstruction of the disc from c3-c7 following single-level discectomy for intractable radiculopathy and/or myelopathy. The bryan device is implanted via an open anterior approach. Intractable radiculopathyand/or myelopathy is defined as any combination of the following: disc herniation withradiculopathy. Spondylotic radiculopathy, disc herniation with myelopathy, or spondyloticmyelopathy resulting in impaired function and at least one clinical neurological sign associatedwith the cervical level to be treated, and necessitating surgery as demonstrated using computedtomography (ct), myelography and ct, and/or magnetic resonance imaging (mr1). Patientsreceiving the bryan cervical disc should have failed at least six weeks of non-operative treatment prior to implantation of the bryan cervical disc.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S004 S005